Correlation Between Ignyte Acquisition and Adhera Therapeutics

Can any of the company-specific risk be diversified away by investing in both Ignyte Acquisition and Adhera Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ignyte Acquisition and Adhera Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Ignyte Acquisition Corp and Adhera Therapeutics, you can compare the effects of market volatilities on Ignyte Acquisition and Adhera Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ignyte Acquisition with a short position of Adhera Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ignyte Acquisition and Adhera Therapeutics.

Diversification Opportunities for Ignyte Acquisition and Adhera Therapeutics

0.0

Correlation Coefficient

Ignyte Acquisition  Adhera Therapeutics

Pay attention - limited upside

The 3 months correlation between Ignyte and Adhera is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Ignyte Acquisition Corp and Adhera Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Adhera Therapeutics and Ignyte Acquisition is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ignyte Acquisition Corp are associated (or correlated) with Adhera Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Adhera Therapeutics has no effect on the direction of Ignyte Acquisition i.e., Ignyte Acquisition and Adhera Therapeutics go up and down completely randomly.

Pair Corralation between Ignyte Acquisition and Adhera Therapeutics

If you would invest (100.00) in Adhera Therapeutics on December 26, 2024 and sell it today you would earn a total of  100.00  from holding Adhera Therapeutics or generate -100.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Flat
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Ignyte Acquisition Corp  vs.  Adhera Therapeutics

Ignyte Acquisition Corp

Risk-Adjusted Performance

Very Weak

Over the last 90 days Ignyte Acquisition Corp has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable basic indicators, Ignyte Acquisition is not utilizing all of its potentials. The recent stock price fuss, may contribute to near-short-term losses for the sophisticated investors.

Adhera Therapeutics

Risk-Adjusted Performance

Very Weak

Over the last 90 days Adhera Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong basic indicators, Adhera Therapeutics is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with Ignyte Acquisition and Adhera Therapeutics

The main advantage of trading using opposite Ignyte Acquisition and Adhera Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ignyte Acquisition position performs unexpectedly, Adhera Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Adhera Therapeutics will offset losses from the drop in Adhera Therapeutics' long position.

The idea behind Ignyte Acquisition Corp and Adhera Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.